BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2178379)

  • 1. Effect of diltiazem on cardiac rate and rhythm after myocardial infarction. Multicenter Diltiazem Postinfarction Trial Investigators.
    Bigger JT; Coromilas J; Rolnitzky LM; Fleiss JL; Kleiger RE
    Am J Cardiol; 1990 Mar; 65(9):539-46. PubMed ID: 2178379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study.
    Bloch Thomsen PE; Jons C; Raatikainen MJ; Moerch Joergensen R; Hartikainen J; Virtanen V; Boland J; Anttonen O; Gang UJ; Hoest N; Boersma LV; Platou ES; Becker D; Messier MD; Huikuri HV;
    Circulation; 2010 Sep; 122(13):1258-64. PubMed ID: 20837897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial).
    Marcus FI; Friday K; McCans J; Moon T; Hahn E; Cobb L; Edwards J; Kuller L
    Am J Cardiol; 1990 Mar; 65(9):559-66. PubMed ID: 2178380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between diltiazem and left ventricular function after myocardial infarction. Multicenter Diltiazem Post-Infarction Research Group.
    Moss AJ; Oakes D; Benhorin J; Carleen E
    Circulation; 1989 Dec; 80(6 Suppl):IV102-6. PubMed ID: 2688978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
    Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
    Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting.
    Hannes W; Fasol R; Zajonc H; Schindler M; Schumacher B; Schlosser V; Holubarsch CH; Seitelberger R
    Eur J Cardiothorac Surg; 1993; 7(5):239-45. PubMed ID: 8517952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
    J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.
    Wong SC; Greenberg H; Hager WD; Dwyer EM
    J Am Coll Cardiol; 1992 Jun; 19(7):1421-5. PubMed ID: 1593034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of verapamil on arrhythmias and heart rate during 16 months following an acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    Vaage-Nilsen M; Rasmussen V; Hansen JF; Hagerup L; Sørensen MB; Pedersen-Bjergaard O; Mellemgaard K; Holländer NH; Nielsen I; Sigurd BM
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):147-51. PubMed ID: 8086325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting.
    Seitelberger R; Hannes W; Gleichauf M; Keilich M; Christoph M; Fasol R
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):811-21. PubMed ID: 8127110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators.
    el-Sherif N; Denes P; Katz R; Capone R; Mitchell LB; Carlson M; Reynolds-Haertle R
    J Am Coll Cardiol; 1995 Mar; 25(4):908-14. PubMed ID: 7884096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Moss AJ; Oakes D; Rubison M; McDermott M; Carleen E; Eberly S; Brown M
    Am J Cardiol; 1991 Aug; 68(5):429-33. PubMed ID: 1872266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram.
    Farrell TG; Bashir Y; Cripps T; Malik M; Poloniecki J; Bennett ED; Ward DE; Camm AJ
    J Am Coll Cardiol; 1991 Sep; 18(3):687-97. PubMed ID: 1822090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.
    Goldstein RE; Boccuzzi SJ; Cruess D; Nattel S
    Circulation; 1991 Jan; 83(1):52-60. PubMed ID: 1984898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Messerli FH; Hansen JF; Gibson RS; Schechtman KB; Boden WE
    J Hypertens; 2001 May; 19(5):977-82. PubMed ID: 11393682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study.
    Gibson RS; Young PM; Boden WE; Schechtman K; Roberts R
    Am J Cardiol; 1987 Aug; 60(4):203-9. PubMed ID: 3303886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of reinfarction subsequent to non-Q-wave infarction.
    Roberts R; Gibson RS
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S36-46. PubMed ID: 2468975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.